{"altmetric_id":1362665,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":16},"twitter":{"unique_users_count":10,"unique_users":["Transplant_Doc","SCTNB","hemedoc","CancerMedMDA","Myeloma_Doc","hematologo","emircervera","FrancescoTurtu1","MRDResearch","emiliomonteb"],"posts_count":16}},"selected_quotes":["Study of #myeloma treatment in US: large decrease in conventional drug use (1999-2007), increase in novel agents (","Study of #myeloma treatment in US: increase in use of auto stem cell transplant from 1999-2007 (11.1% to 21.7%)(","Absence of minimal residual disease by flow cytometry after an autotransplant predicts longer survival in myeloma","Study of #myeloma treatment: Medicare Medicaid patients less likely to get novel agents vs. private insurance ( )."],"citation":{"abstract":"Despite improved outcomes for multiple myeloma, little is known about changes in initial treatment at the population level for US patients. We report trends in treatment practices.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e93cf058f610005a18","doi":"10.1200\/jco.2012.46.3323","first_seen_on":"2013-04-11T13:01:32+00:00","issns":["1527-7755"],"journal":"Journal of Clinical Oncology","last_mentioned_on":1375105214,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23569317"],"pmid":"23569317","pubdate":"2013-04-08T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Multiple Myeloma Treatment Transformed: A Population-Based Study of Changes in Initial Management Approaches in the United States.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/multiple-myeloma-treatment-transformed-populationbased-study-changes-initial-management-approaches-u-6"},"altmetric_score":{"score":4.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.85},"context_for_score":{"all":{"total_number_of_other_articles":6574670,"mean":6.0975551888622,"rank":1202860,"this_scored_higher_than_pct":81,"this_scored_higher_than":5365074,"rank_type":"exact","sample_size":6574670,"percentile":81},"similar_age_3m":{"total_number_of_other_articles":100935,"mean":6.9737081062873,"rank":20976,"this_scored_higher_than_pct":79,"this_scored_higher_than":79810,"rank_type":"exact","sample_size":100935,"percentile":79},"this_journal":{"total_number_of_other_articles":6710,"mean":12.71443821732,"rank":2756,"this_scored_higher_than_pct":58,"this_scored_higher_than":3932,"rank_type":"exact","sample_size":6710,"percentile":58},"similar_age_this_journal_3m":{"total_number_of_other_articles":80,"mean":6.7890379746835,"rank":27,"this_scored_higher_than_pct":66,"this_scored_higher_than":53,"rank_type":"exact","sample_size":80,"percentile":66}}},"demographics":{"poster_types":{"member_of_the_public":6,"researcher":3,"practitioner":1},"users":{"twitter":{"cohorts":{"Scientists":3,"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":6}},"mendeley":{"by_status":{"Student  > Doctoral Student":1},"by_discipline":{"Medicine and Dentistry":1}}},"geo":{"twitter":{"CA":1,"US":5,"MX":1,"ES":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/322664179553148929","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-12T10:55:09+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"322664179553148929"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/322664246506835969","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-12T10:55:25+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"322664246506835969"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/322664265037258752","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-12T10:55:30+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"322664265037258752"},{"url":"http:\/\/twitter.com\/SCTNB\/statuses\/325606277281611776","license":"datasift","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-20T13:46:00+00:00","author":{"name":"Dr T. Comeau , MD","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000365246082\/373bc9bced36e8f90f0d52d727fc6b34_normal.jpeg","description":"Director New Brunswick Stem Cell Transplant Program ; SCT Physician ; #hematology: #leukemia, #MDS, #lymphoma, #mmsm , #apheresis, #bmtsm , #immunotherapy","id_on_source":"SCTNB","tweeter_id":"314498013","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":1131},"tweet_id":"325606277281611776"},{"url":"http:\/\/twitter.com\/Transplant_Doc\/statuses\/341927238616354816","license":"public","citation_ids":[1362665],"posted_on":"2013-06-04T14:39:41+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"Transplant_Doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3370},"tweet_id":"341927238616354816"},{"url":"http:\/\/twitter.com\/hemedoc\/statuses\/341966116639354880","license":"public","rt":["Transplant_Doc"],"citation_ids":[1362665],"posted_on":"2013-06-04T17:14:10+00:00","author":{"name":"Aaron Logan, MD, PhD","url":"http:\/\/profiles.ucsf.edu\/aaron.logan","image":"https:\/\/pbs.twimg.com\/profile_images\/3744112126\/2d3cdd63fb326b488a21eafe44916d77_normal.jpeg","description":"UCSF hematology & BMT physician. Translational researcher w\/ interest in leukemia, lymphoma, myeloma, MRD, post-HCT relapse, GVHD, and immune reconstitution.","id_on_source":"hemedoc","tweeter_id":"55141488","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":2307},"tweet_id":"341966116639354880"},{"url":"http:\/\/twitter.com\/CancerMedMDA\/statuses\/342308547775840256","license":"public","rt":["Transplant_Doc"],"citation_ids":[1362665],"posted_on":"2013-06-05T15:54:52+00:00","author":{"name":"Cancer Medicine","url":"http:\/\/www.mdanderson.org\/cancermedicine","image":"https:\/\/pbs.twimg.com\/profile_images\/876836086554677249\/pl7C_g0f_normal.jpg","description":"Mission of largest MD Anderson division is to eliminate cancer via best, integrated patient care, research & education programs. Appts.available 877-632-6789.","id_on_source":"CancerMedMDA","tweeter_id":"851503992","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":3376},"tweet_id":"342308547775840256"},{"url":"http:\/\/twitter.com\/Myeloma_Doc\/statuses\/322333389980053504","license":"public","citation_ids":[1362665],"posted_on":"2013-04-11T13:00:43+00:00","author":{"name":"Robert Z. Orlowski","url":"http:\/\/faculty.mdanderson.org\/robert_orlowski\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1118389100\/-1_normal.jpg","description":"Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets \u2260 endorsements.","id_on_source":"Myeloma_Doc","tweeter_id":"187354183","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":7327},"tweet_id":"322333389980053504"},{"url":"http:\/\/twitter.com\/Myeloma_Doc\/statuses\/322333710596841472","license":"public","citation_ids":[1362665],"posted_on":"2013-04-11T13:01:59+00:00","author":{"name":"Robert Z. Orlowski","url":"http:\/\/faculty.mdanderson.org\/robert_orlowski\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1118389100\/-1_normal.jpg","description":"Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets \u2260 endorsements.","id_on_source":"Myeloma_Doc","tweeter_id":"187354183","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":7327},"tweet_id":"322333710596841472"},{"url":"http:\/\/twitter.com\/Myeloma_Doc\/statuses\/322334048380919808","license":"public","citation_ids":[1362665],"posted_on":"2013-04-11T13:03:20+00:00","author":{"name":"Robert Z. Orlowski","url":"http:\/\/faculty.mdanderson.org\/robert_orlowski\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1118389100\/-1_normal.jpg","description":"Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets \u2260 endorsements.","id_on_source":"Myeloma_Doc","tweeter_id":"187354183","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":7327},"tweet_id":"322334048380919808"},{"url":"http:\/\/twitter.com\/hematologo\/statuses\/322334602666602496","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-11T13:05:32+00:00","author":{"name":"Dr. Luis Villela","image":"http:\/\/pbs.twimg.com\/profile_images\/463700121901756417\/EBv1Scza_normal.png","description":"Happily married. Hematologist & Stem Cell Transplantation Centro Medico Zambrano Hellion. Hem & cancer endowment. Clinical Research. ITESM TEC SALUD.","id_on_source":"hematologo","tweeter_id":"120125682","geo":{"lt":"22.5000485","ln":"-100.0000375","country":"MX"},"followers":262},"tweet_id":"322334602666602496"},{"url":"http:\/\/twitter.com\/emircervera\/statuses\/322335983737655296","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-11T13:11:01+00:00","author":{"name":"eduardo cervera","image":"https:\/\/pbs.twimg.com\/profile_images\/795467364456284160\/SQMFZVc3_normal.jpg","id_on_source":"emircervera","tweeter_id":"429588704","geo":{"lt":null,"ln":null},"followers":306},"tweet_id":"322335983737655296"},{"url":"http:\/\/twitter.com\/emircervera\/statuses\/322336036971749376","license":"public","rt":["Myeloma_Doc"],"citation_ids":[1362665],"posted_on":"2013-04-11T13:11:14+00:00","author":{"name":"eduardo cervera","image":"https:\/\/pbs.twimg.com\/profile_images\/795467364456284160\/SQMFZVc3_normal.jpg","id_on_source":"emircervera","tweeter_id":"429588704","geo":{"lt":null,"ln":null},"followers":306},"tweet_id":"322336036971749376"},{"url":"http:\/\/twitter.com\/FrancescoTurtu1\/statuses\/340091975153885184","license":"public","citation_ids":[1362665],"posted_on":"2013-05-30T13:07:00+00:00","author":{"name":"Francesco Turturro","url":"http:\/\/faculty.mdanderson.org\/Francesco_Turturro\/Default.asp?SNID=1484660469","image":"https:\/\/pbs.twimg.com\/profile_images\/763530448618217472\/8el8ozjZ_normal.jpg","description":"Lymphoma specialist expressing his own opinions","id_on_source":"FrancescoTurtu1","tweeter_id":"1191609930","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":968},"tweet_id":"340091975153885184"},{"url":"http:\/\/twitter.com\/MRDResearch\/statuses\/348508396527427584","license":"datasift","rt":["Transplant_Doc"],"citation_ids":[1362665],"posted_on":"2013-06-22T18:30:51+00:00","author":{"name":"MRD Cancer Research","url":"http:\/\/t.co\/SHyCVQeqhl","image":"http:\/\/a0.twimg.com\/profile_images\/378800000030320689\/720cc9044acbf3819bef7a0418e36220_normal.png","description":"Minimal Residual Disease (#MRD) is residual #cancer cells which survived standard treatment & is the leading cause of cancer relapse. #MinimalResidualDisease","id_on_source":"MRDResearch","tweeter_id":"1539133854","geo":{"lt":37.777125,"ln":-122.419644,"country":"US"},"followers":4},"tweet_id":"348508396527427584"},{"url":"http:\/\/twitter.com\/emiliomonteb\/statuses\/361843612524363776","license":"datasift","citation_ids":[1362665],"posted_on":"2013-07-29T13:40:14+00:00","author":{"name":"Emilio Monte","url":"https:\/\/www.linkedin.com\/in\/emilio-monte-boquet-67032624\/","image":"https:\/\/pbs.twimg.com\/profile_images\/898548741422153728\/en1Mia9R_normal.jpg","description":"#Farmacia #HospitalLaFe #HospitalPharmacy PharmD PhD #eSalud #eHealth #Sherpas20 @ufpelafe @eDruida_","id_on_source":"emiliomonteb","tweeter_id":"51391835","geo":{"lt":39.5,"ln":-0.75,"country":"ES"},"followers":3631},"tweet_id":"361843612524363776"}]}}